MOODY LYNN & LIEBERSON, LLC – Neurocrine Biosciences, Inc. Transaction History
MOODY LYNN & LIEBERSON, LLC portfolio value:
$3.68M
portfolio value
MOODY LYNN & LIEBERSON, LLC quarter portfolio value change:
+8.96%
quarter
Neurocrine Biosciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -0.01% | -5 shares | 302K | $106.21 | 34.68K |
| Q2 2022 | share | Increase | 0.00% | 34.68K shares | 3.38M | $97.48 | 34.68K |
| Q4 2020 | share | Decrease | -100.00% | -10.35K shares | -995K | $95.85 | 0 |
| Q3 2020 | share | Increase | 0.00% | 10.35K shares | 995K | $96.16 | 10.35K |
| Q4 2018 | share | Decrease | -100.00% | -4.24K shares | -522K | $71.41 | 0 |
| Q3 2018 | share | Increase | 0.00% | 4.24K shares | 522K | $122.95 | 4.24K |